Tag: Virtual

Asia Society Hong Kong Thanksgiving Virtual Gala

This October 2020, Asia Society Hong Kong (ASHK) will celebrate its 30th anniversary.  We will hold a virtual Thanksgiving Gala on Tuesday, November 17, 2020 from 7 to 8:30 p.m. ASHK will take this momentous occasion to honor 12 visionaries who have been instrumental in the establishment of Asia Society in Hong Kong. We are delighted to honor Sir Q.W. Lee, Robert B. Oxnam, Jack Tang, Hong Kong Jockey Club, Robert and Chantal Miller, Mochtar Riady, Burton Levin, Nicholas Platt, Tung Chee-hwa, Chien Lee, Mary Lee Turner, and John S. Wadsworth Jr.

To show our appreciation at this time of giving, we will showcase ASHK’s diverse contribution to the city: Fireside chats with inspiring leaders of Hong Kong (12 highly respected honorees), in-depth and timely political discussion on the future of the Sino-American relationship under the new U.S. administration, and some special music performances. To conclude the evening, we will welcome guests to an after party from 8:30 to 9:15 p.m. True to our mission, we promise to inspire, unite and connect!

2020 has been challenging for Hong Kong, and ASHK is not immune to its effects. Despite the adversities, we continue to steer ahead and provide you with different programs and events in innovative ways. Proceeds from this gala will contribute significantly to our mission of educating people about the countries and culture of Asia and global issues that impact the region.

Please find more details on table sponsorship and ticket purchase here. Any donation will be matched 1:1 thanks to a matching initiative from the ASHK Board of Trustees.


Fireside Chat: The Future of U.S.-China Relations

At Asia Society Hong Kong Center, our mission is to promote mutual understanding and strengthen partnerships among peoples, leaders and institutions in Asia and the West. Being nestled in Hong Kong, a global city and geopolitical hotspot where East meets West, U.S.-China relations remain front and centre. As we come together for a revered American tradition to celebrate togetherness, join us for a dialogue for which we unite high-ranking U.S. and Chinese diplomats for an engaging conversation on the future of the Sino-American relationship under the new U.S. administration.


Menu

Thank you for considering supporting our gala. ASHK has partnered with a number of local Hong Kong restaurants. Acknowledging how hard they have affected by Covid-19, we hope to provide some much needed support to the Food and Beverage Industry while providing diverse dinner options for our guests.  


2020 Asia Society Hong Kong Gala Honorees

FOUNDERS

  • Sir Q.W. Lee (in memoriam)

 

 

 

 

 

 

 

 

 


VISIONARIES

 

 

 

  • Robert and Chantal Miller

 

 

 

 

 

 


STATESMEN

  • Burton Levin (in memoriam)

 

 

 

 

 

 

 

 

 


BUILDERS

 

 

 

 

 

 


Partners:


Sponsorship:

  • Table Sponsorship           HK$38,000
  • Individual Ticket               HK$4,000

For further information, please contact Ms. Anjali Grover, Head of Strategic Development at agrover@asiasociety.org or (852)2103-9536.

DONATE

Source Article

Continue reading

Bill to allow virtual government meetings headed to Whitmer for signature

LANSING, MI – Guidance on public and virtual meetings could be headed to local governments across the state after the passage of a bill in the legislature.

In the wake of the Michigan Supreme Court striking down Gov. Gretchen Whitmer’s executive orders last week, a handful of local entities quickly nixed public meetings scheduled to be held via Zoom. Whitmer’s executive orders allowed public bodies to hold electronic meetings since March. Remotely held meetings of public bodies could otherwise violate the Open Meetings Act.

Senate Bill 1108, sponsored by state Sen. Lana Theis, R-Brighton, would permit virtual public meetings as long as the local government declares a state of emergency. It passed 85-16 during House a session Tuesday, Oct. 13.

It passed 36-1 in the Senate later Tuesday night. The bill now heads to Whitmer’s desk for final consideration.

The legislation would allow for virtual meetings by local governments until December 2021. The bill also seeks to clear up the question of whether local governments violated the Open Meetings Act after April 30, since the Michigan Supreme Court invalidated Whitmer’s executive orders after that date.

The bill also replaces elements of Whitmer’s executive order allowing for virtual meetings. Those include requiring an explanation within 18 hours of the meeting for why it needs to be held virtually, ensuring two-way communication for members to hear each other, posting agenda updates online and establishing how the public can view meetings.

There were dissenting comments from both Republican and Democratic representatives that signaled lingering issues with elements of the bill.

In its current form, the bill would allow members of public bodies to remotely tune in and vote during in-person meetings under certain circumstances, including required military duty, a medical condition or a state of emergency that would “risk the personal health or safety of members of the public or the public body,” according to analysis from the House Fiscal Agency.

The last two provisions prompted proposed amendments by Rep. Beau LaFave, R-Iron Mountain. He suggested that medical conditions must require quarantine to allow an absence by a local official. If that person is hospitalized, he also suggested they be required to be in hospital within 100 miles of the public meeting to be involved in the vote.

“There’s no requirement that the individual be even sick with COVID-19,” he said on the House floor. “They could’ve broken their leg, and could avoid the scrutiny of the public and get around the Open Meetings Act and the transparency to the public that goes along with it.”

Lastly, the state of emergency should be one linked to the COVID-19 pandemic, and not something such as flooding or fires, he proposed. The amendment was denied.

Additionally, Rep. Matt Koleszar, D-Plymouth, offered an amendment calling for the allowance of virtual meetings until March 2022, rather than the end of next year. That amendment was also scrapped.

Local municipalities have been dealing with the issue of meeting virtually since last week’s Supreme Court decision. On Monday, Oct.

Continue reading

SEngine Precision Medicine to Present at Society of Functional Precision Medicine Virtual …

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

SEATTLE, Oct. 13, 2020 (GLOBE NEWSWIRE) — SEnginePrecision Medicine, a precision oncology company revolutionizing cancer diagnostics and drug discovery by pre-testing drugs on patient-derived tumor organoids, today announced that Chief Medical Officer Astrid L. Margossian, MD, PhD, will present at the Society for Functional Precision Medicine (SFPM) Virtual Monthly Seminar on October 14th at 11:30 am ET.

Dr. Margossian is leading SEngine’s clinical validation initiatives for the PARIS® Test, a CLIA certified cancer organoid based drug sensitivity test for all solid tumors. The presentation is entitled, “Predictive Clinical Value of a CLIA-Approved Organoid Based Drug Sensitivity Test,” and will highlight the data on the PARIS® Test, recently presented at the ASCO 2020 and ACCR 2020 annual meetings, inclusive of organoids sensitivity results, showing clinical correlation with genomics and previous clinical treatments. Registration for the live event is available for free at https://www.sfpm.io/seminars.php.

SFPM’s virtual monthly seminar brings together distinguished guest speakers and through interactive panel discussions and Q&A sessions focuses on these key topics:

  • Demonstrating the clinical utility of functional precision medicine testing
  • Implementing functional testing in precision medicine clinical trials
  • Accelerating the application of functional testing
  • Addressing stakeholder, educational and investment challenges for functional precision medicine

About PARIS® Test
The CLIA certified PARIS® Test is based on the capability to propagate patient-specific cancer tissue as organoids ex vivo and is applicable to all solid tumors including colon, breast, lung, ovarian and pancreatic cancer. Organoids are cancer-derived cells grown in 3D outside the body, which maintain the functionality of the original tumor as well as its genomic characteristics. For cancers where the path is not clear, such as many metastatic and recurrent cancers, the PARIS test provides crucial information to the treating physicians to match the right drug to the right patient.

About SEngine Precision Medicine
SEngine Precision Medicine Inc. is a precision oncology company revolutionizing cancer diagnostics and therapies by pre-testing drugs on patient-derived organoids grown ex-vivo utilizing patient specific tumor cells. As a spin-out from the world-renowned Fred Hutchinson Cancer Research Center, SEngine is leveraging over two decades of R&D in diagnostics and drug discovery. The Company is commercializing the PARIS® Test, a next generation diagnostic test that predicts drug responses integrating knowledge of cancer genomics with organoids, robotics, and AI-driven computational tools. SEngine’s CLIA certified PARIS® Test generates predictive drug sensitivity reports for patients with solid tumors. SEngine is also pursuing drug discovery via strategic collaborations with biopharmaceutical / pharma companies leveraging its precision oncology platform.

Discover more at SengineMedicine.com and follow the latest news from SEngine on Twitter at @SEngineMedicine and on LinkedIn.

Contact:
Stephanie Carrington
stephanie.carrington@westwicke.com
646-277-1282

Source Article

Continue reading

Castle Biosciences Presents Data at the 2020 American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting


Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced that its data were featured in two oral presentations during the 2020 American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting, Oct. 9-11, 2020.


DecisionDx®-Melanoma: Skin Cancer and Reconstruction Session; Friday, October 9, 2020


“Cutaneous Melanoma Prognostic Model Combining 31-gene Expression Profile and Sentinel Lymph Node Biopsy” was presented by Aaron Farberg, M.D., Baylor University Medical Center, Dallas, Texas.


DecisionDx-Melanoma is a gene expression profile test that uses an individual patient’s tumor biology to predict individual risk of cutaneous melanoma metastasis or recurrence, as well as sentinel lymph node positivity, independent of traditional staging factors.


“As most sentinel lymph node biopsies are negative, there is a need to identify which melanoma patients can forgo sentinel lymph node biopsy (SNLB),” said Dr. Farberg. “Based on the cohort described in a recent meta-analysis by Greenhaw and colleagues, we modeled the use of Castle’s DecisionDx-Melanoma test to determine whether it might alter the predictive value of SLNB alone in high-risk patients, and whether the test might identify patients who would not benefit from SLNB. In fact, we found that use of the test stratifies risk in the cohort studied, which can help focus the resources needed for SLNB on patients with genuinely higher risk, thereby reducing surgical risks for patients who can avoid SLNB.”


Study methods and findings:


  • The study objective was to model the use of DecisionDx-Melanoma to triage cutaneous melanoma patients for SLNB, to evaluate the outcomes of low-risk patients who can forgo SLNB and to evaluate the combined accuracy of DecisionDx-Melanoma and SLNB in high-risk patients.

  • The model was based on use of DecisionDx-Melanoma to triage the patients from the recently published systematic review and meta-analysis (Greenhaw et al. JAAD, Sept., 2020), assuming that:

    • Patients with a Class 1A result who were 55 years of age or older with T1-T2 melanoma would not undergo SLNB;

    • The negative predictive value of DecisionDx-Melanoma for recurrence-free survival, distant metastasis free survival and ultimately melanoma specific survival would be high for patients who would not have undergone SLNB due to DecisionDx-Melanoma triage; and

    • The remaining patients would undergo SLNB.

  • Result showed that:

    • 69% of all patients could forgo an SLNB due to a DecisionDx-Melanoma Class 1A test result, and the negative predictive value for 5-year melanoma specific survival was 98%.

    • For the remaining 31% of patients who would undergo an SLNB:

      • Sensitivity for melanoma specific death was 87% for DecisionDx-Melanoma compared with 73% for SLNB. Combining DecisionDx-Melanoma with SLNB improved sensitivity to 96%.

      • Negative predictive value for melanoma specific death was 95% for DecisionDx-Melanoma, compared with 94% for SLNB. Combining DecisionDx-Melanoma with SLNB improved negative predictive value to 98%.

  • The study concluded that use of DecisionDx-Melanoma to triage patients with
Continue reading

Tricida Announces Twelve Data Presentations on Veverimer and Metabolic Acidosis to be Given at the Virtual American Society of Nephrology Kidney Week 2020

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD), announced today that it has authored or sponsored 12 presentations at the upcoming American Society of Nephrology (ASN) Kidney Week 2020 being held virtually October 22-25, 2020. Data to be presented at multiple sessions at the meeting will expand the breadth of information about the implications of metabolic acidosis and CKD. All Tricida presentations will be available on Thursday, October 22, 2020 at 10:00am ET. Session and presentation titles are listed below:

Session Title: CKD Risk Factors: Diet, Environment, Lifestyle

Title:

Relationship Between Metabolic Acidosis and Chronic Kidney Disease Progression is Evident Across United States Racial and Ethnic Groups

Author:

N. Tangri et al.

ePoster #:

PO0468

 

 

Title:

Metabolic Acidosis is Associated with Chronic Kidney Disease Progression: A Longitudinal Analysis of >100,000 United States Community-Based Patients

Author:

V. Mathur et al.

ePoster #:

PO0469

 

 

Title:

Metabolic Acidosis and Progression to Renal Replacement Therapy (Encore Presentation)

Author:

V. Mathur et al.

ePoster #:

PO0467

Session Title: Advances in Geriatric Nephrology

Title:

Effects of Veverimer on Serum Bicarbonate and Physical Function in Elderly Patients with Metabolic Acidosis in Chronic Kidney Disease

Author:

D. Wesson et al.

ePoster #:

PO1685

 

 

Title:

Correlation Between Patient-Reported Physical Limitation and Objective Physical Performance on the Repeated Chair Stand Test Among Patients with Non-Dialysis Dependent Chronic Kidney Disease and Metabolic Acidosis

Author:

V. Mathur et al.

ePoster #:

PO1687

Session Title: CVD, BP, and Kidney Diseases: Exploring the Link

Title:

No Adverse Effects of Veverimer on Volume Status or Blood Pressure in Patients with Chronic Kidney Disease and Metabolic Acidosis

Author:

D. Wesson et al.

ePoster #:

PO2116

Session Title: Women’s Health and Kidney Diseases

Title:

Effects of Veverimer on Serum Bicarbonate and Physical Function in Women with Chronic Kidney Disease: A Subgroup Analysis from a Randomized Controlled Trial

Author:

V. Mathur et al.

Session:

Women’s Health and Kidney Diseases

ePoster #:

PO2612

Session Title: Diabetic Kidney Disease: Clinical – 2

Title:

Effects of Veverimer on Serum Bicarbonate and Physical Function in Patients with Diabetes and Chronic Kidney Disease: Subgroup Analysis from a Randomized Trial (Encore presentation)

Author:

D. Wesson et al.

ePoster #:

PO1033

Session Title: Fluid, Electrolyte, and Acid-Base Disorders: Clinical – 2

Title:

Metabolic Acidosis is a Predictive Factor for All-Cause Mortality in Patients with Chronic Kidney Disease (Encore presentation)

Author:

N. Tangri et al.

ePoster #:

PO1483

Session Title: Pharmacology (PharmacoKinetics, -Dynamics, -Genomics)

Title:

Action of Veverimer on Gastrointestinal Acid Binding is Not Affected by Omeprazole

Author:

D. Parsell et al.

ePoster #:

PO2374

 

 

Title:

Evaluation of Veverimer Drug Interaction Potential (Encore presentation)

Author:

J. Shao et al.

ePoster #:

PO2373

Session Title: Informational Posters

Title:

Understanding the Long-Term Impact of Metabolic Acidosis in Chronic Kidney Disease: Design of the ULTIMA-CKD Patient Registry

Author:

V. Mathur et al.

ePoster #:

INFO16

Continue reading

Allergan Aesthetics To Present Data From 4 Abstracts At The 2020 American Society For Dermatologic Surgery Virtual Meeting

IRVINE, Calif., Oct. 9, 2020 /PRNewswire/ — Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced today that it will present 4 abstracts at the annual American Society for Dermatologic Surgery (ASDS) virtual meeting from October 9-11, 2020.

The scheduled times (noted in local Eastern Standard Time) of the presentations, titles and authors are as follows.

Oral presentations include:

  • Patient Satisfaction Following Chin Augmentation With Hyaluronic Acid Fillers: A Pooled Analysis
  • Authors: Joely Kaufman, Patricia Ogilvie, Kenneth Beer, Alexander Rivkin, Sarah Baradaran, Andrew Schumacher
  • Presenter: Joely Kaufman, MD
  • Saturday, October 10th, 11:27 a.m.
  • Treatment of Upper Facial Lines With OnabotulinumtoxinA Results in Long-Lasting Efficacy and Patient Satisfaction
    • Authors: Joel L. Cohen, Koenraad De Boulle, Steven Fagien, Jean Carruthers, Sue Ellen Cox, Patricia Ogilvie, Julie Garcia, Sara Sangha
    • Presenter: Joel L. Cohen, MD
    • Sunday, October 11th, 10:27 a.m.

    The following posters will be on display and available for the entire length of the ASDS Virtual Annual Meeting.

    • Safety, Pharmacodynamic Response, and Treatment Satisfaction With OnabotulinumtoxinA 40 U, 60 U, and 80 U in Subjects With Moderate to Severe Dynamic Glabellar Lines
    • Authors: Sue Ellen Cox, John H. Joseph, Steven Fagien, Dee Anna Glaser, Suzanne Bruce, Edward Lain, Steven Yoelin, Melanie Palm, Corey S. Maas, Xiaofang Lei, John Maltman, Sara Sangha, Mitchell Brin
  • Global Patient Perspectives on Skin Quality in Facial Aesthetics
    • Authors: Noëlle Sherber, Annie Chiu, Arisa Ortiz, Shannon Humphrey, Jeanine Downie, Sabrina Fabi

    Complete abstracts, details on presentation times and changes to presentation dates can be found on the ASDS website. The above listed dates are subject to change. Please check www.asds.net for the latest information.

    IMPORTANT SAFETY INFORMATION & APPROVED USES
    BOTOX® Cosmetic may cause serious side effects that can be life threatening. Get medical help right away if you have any of these problems any time (hours to weeks) after injection of BOTOX® Cosmetic:

    • Problems swallowing, speaking, or breathing, due to weakening of associated muscles, can be severe and result in loss of life. You are at the highest risk if these problems are pre-existing before injection. Swallowing problems may last for several months.
    • Spread of toxin effects. The effect of botulinum toxin may affect areas away from the injection site and cause serious symptoms including: loss of strength and all-over muscle weakness, double vision, blurred vision and drooping eyelids, hoarseness or change or loss of voice, trouble saying words clearly, loss of bladder control, trouble breathing, and trouble swallowing.

    BOTOX® Cosmetic dosing units are not the same as, or comparable to, any other botulinum toxin product.
    There has not been a confirmed serious case of spread of toxin effect when BOTOX® Cosmetic has been used at the recommended dose to treat frown lines, crow’s feet lines, and/or forehead lines.
    BOTOX® Cosmetic may cause loss of strength or general

    Continue reading

    Allergan Aesthetics To Present Data From 4 Abstracts At The 2020 American Society For Dermatologic Surgery Virtual Meeting | Nachricht

    IRVINE, Calif., Oct. 9, 2020 /PRNewswire/ –Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced today that it will present 4 abstracts at the annual American Society for Dermatologic Surgery (ASDS) virtual meeting from October 9-11, 2020.

    The scheduled times (noted in local Eastern Standard Time) of the presentations, titles and authors are as follows.

    Oral presentations include:

    • Patient Satisfaction Following Chin Augmentation With Hyaluronic Acid Fillers: A Pooled Analysis
    • Authors: Joely Kaufman, Patricia Ogilvie, Kenneth Beer, Alexander Rivkin, Sarah Baradaran, Andrew Schumacher
    • Presenter: Joely Kaufman, MD
    • Saturday, October 10th, 11:27 a.m.
  • Treatment of Upper Facial Lines With OnabotulinumtoxinA Results in Long-Lasting Efficacy and Patient Satisfaction
    • Authors: Joel L. Cohen, Koenraad De Boulle, Steven Fagien, Jean Carruthers, Sue Ellen Cox, Patricia Ogilvie, Julie Garcia, Sara Sangha
    • Presenter: Joel L. Cohen, MD
    • Sunday, October 11th, 10:27 a.m.

    The following posters will be on display and available for the entire length of the ASDS Virtual Annual Meeting.

    • Safety, Pharmacodynamic Response, and Treatment Satisfaction With OnabotulinumtoxinA 40 U, 60 U, and 80 U in Subjects With Moderate to Severe Dynamic Glabellar Lines
    • Authors: Sue Ellen Cox, John H. Joseph, Steven Fagien, Dee Anna Glaser, Suzanne Bruce, Edward Lain, Steven Yoelin, Melanie Palm, Corey S. Maas, Xiaofang Lei, John Maltman, Sara Sangha, Mitchell Brin
  • Global Patient Perspectives on Skin Quality in Facial Aesthetics
    • Authors: Noëlle Sherber, Annie Chiu, Arisa Ortiz, Shannon Humphrey, Jeanine Downie, Sabrina Fabi

    Complete abstracts, details on presentation times and changes to presentation dates can be found on the ASDS website. The above listed dates are subject to change. Please check www.asds.net for the latest information.

    IMPORTANT SAFETY INFORMATION & APPROVED USES
    BOTOX® Cosmetic may cause serious side effects that can be life threatening. Get medical help right away if you have any of these problems any time (hours to weeks) after injection of BOTOX® Cosmetic:

    • Problems swallowing, speaking, or breathing, due to weakening of associated muscles, can be severe and result in loss of life. You are at the highest risk if these problems are pre-existing before injection. Swallowing problems may last for several months.
    • Spread of toxin effects. The effect of botulinum toxin may affect areas away from the injection site and cause serious symptoms including: loss of strength and all-over muscle weakness, double vision, blurred vision and drooping eyelids, hoarseness or change or loss of voice, trouble saying words clearly, loss of bladder control, trouble breathing, and trouble swallowing.

    BOTOX® Cosmetic dosing units are not the same as, or comparable to, any other botulinum toxin product.
    There has not been a confirmed serious case of spread of toxin effect when BOTOX® Cosmetic has been used at the recommended dose to treat frown lines, crow’s feet lines, and/or forehead lines.
    BOTOX® Cosmetic may cause loss of strength or general muscle weakness,

    Continue reading

    Schaumburg Twp. Historical Society’s Historic Bus Tour makes virtual stop

    The third annual Historic Bus Tour, sponsored by the Schaumburg Township Historical Society, went virtual in September.

    “Did You Know?” is a video collection of seven important sites that features architectural and historic treasures in Schaumburg Township.

            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            

     

    View highlights of the Schweikher House and Studio, Sunderlage House, Merkle Cabin, Volkening Heritage Farm, Old St. Peter’s Lutheran Church, Schaumburg Center Schoolhouse, and Heritage Park.

    This entertaining and educational tour includes a midcentury modern home, similar to Frank Lloyd Wright-style, listed on the National Registry of Historic Places, plus a two-story historic home, schoolhouse, log cabin, an authentic farmhouse kitchen and more. Discover a new park that celebrates the past.

    Go to www.schaumburgtownship.org to start the virtual tour.

    For information about the Schaumburg Township Historical Society, and to find an additional Schaumburg Township Illinois Bicentennial self-guided tour and map, visit www.s-t-h-s.org.

            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            

    Source Article

    Continue reading

    Utah Huntington’s Disease Society to hold virtual Team Hope Walk | Local News

    The Utah chapter of the Huntington’s Disease Society of America will be hosting its annual Team Hope Walk with a twist this year.

    Due to the COVID-19 pandemic the organization is transitioning into a virtual format, welcoming people to walk wherever they would prefer for the fundraising event on Oct. 17.

    According to the HDSA website, Huntington’s disease is a fatal genetic disorder causing the breakdown of cells in the brain as well as the deterioration of a person’s physical and mental abilities. There are currently 41,000 symptomatic Americans with more than 200,000 at risk of inheriting the disease.

    For Morgan Pratt, the Utah chapter president, Huntington’s disease is something she has been dealing with throughout her life. Pratt’s mother passed away due to complications from the disease and Pratt was then diagnosed with it about two years ago at the age of 23.

    “We are on the cusp of finding a cure,” Pratt said. “They do know what causes Huntington’s disease so I truly believe I am not going to die from Huntington’s disease, it’s just going to be a little blip in my lifetime.”

    For Pratt and the Utah chapter, the Team Hope Walk raised $40,000 last year in hail and inclement weather. This year Pratt said the goal is to raise $60,000 through the virtual event.

    As a result of the COVID-19 pandemic, the organization’s fundraising efforts have taken a big hit and the same has been happening at the national level. Pratt said the national organization had to lay off half of its staff, but she added that the struggles have brought the Huntington’s disease community closer together.

    “We all are quarantined and going through the same sad and depressing emotions, but when you go through hard times together your community grows stronger,” Pratt said.

    According to Pratt, an estimated 300 people in the state of Utah have Huntington’s disease. With the community being so small and tight knit, Pratt brought up how important events like the Team Hope Walk are for people with Huntington’s disease.

    At one virtual fundraiser Pratt attended recently, one of the women in attendance mentioned that it was the first time she had smiled in a month.

    “That truly gave me the chills, that was so fun to connect with her, have fun and shake off those COVID blues,” Pratt said. “The Hope Walk is such a great time to see families and connect with everybody in the community. It’s a great time for us.”

    Pratt also said that the organization is in dire need of donations right now as scientists work to find a cure for Huntington’s disease.

    While putting together events and fundraisers, the Utah HDSA offers monthly support groups for those impacted by Huntington’s disease, and anyone can join.

    While the diagnosis of Huntington’s disease is considered fatal, Pratt found that her diagnosis gave her a new outlook on life, something she feels lucky to have realized at the age of 23.

    “I realized in that moment that

    Continue reading

    Virtual meetings of local government bodies in jeopardy after Supreme Court ruling

    Local governments across Michigan are in limbo following a state Supreme Court ruling, uncertain whether they’ll be able to keep holding public meetings virtually.

    The court last Friday, Oct. 2, struck down Gov. Gretchen Whitmer’s authority to continue Michigan’s state of emergency amid the ongoing COVID-19 pandemic.

    It’s the state of emergency that has empowered Whitmer to unilaterally issue orders like allowing public bodies to hold electronic meetings since March.

    After several months of livestreaming meetings using platforms like Zoom, elected officials around the state are now wondering if they’re going to be forced to return to in-person meetings.

    “Things got even more interesting in this incredibly strange year,” said Ann Arbor City Council Member Ali Ramlawi as the issue came up during a virtual council meeting Monday night.

    While the governor said Friday her orders remain in effect for 21 more days and the Michigan Municipal League has advised cities they can continue to meet virtually during that time, some elected bodies are moving to cancel meetings or return to in-person meetings due to a lack of clarity on the issue.

    The Lansing City Council and Washtenaw County Board of Commissioners are among bodies that canceled their meetings this week due to the uncertainty.

    “Our goal has been and continues to be that we serve as good stewards, not only of the work of running Washtenaw County government, but also good stewards of the health and safety of our staff and residents,” said Washtenaw County Board Chairman Jason Morgan, D-Ann Arbor.

    “We’re postponing our agenda items until our next meeting out of an abundance of caution. We want to ensure we have clarity from the state of Michigan on our legal ability to meet virtually and we are still following the science and abiding by the orders of both our county and state health departments.”

    COVID-19 is still a very real threat, added Washtenaw County Administrator Greg Dill.

    “Until there is a vaccine or a cure, we will continue to take all the necessary precautions to keep everyone safe as we continue to handle (the) business of running Washtenaw County,” he said.

    Police investigating racist, sexist ‘Zoom bomb’ during Washtenaw County meeting

    Grand Blanc Township near Flint held its first in-person meeting in months on Tuesday, Oct. 6.

    Supervisor Scott Bennett said the township decided to follow direction it received from the Michigan Townships Association and others in making the decision.

    “We have business we need to take care of,” Bennett said, adding the township is following Michigan Department of Health and Human Services requirements.

    “We’re following the guidelines for the number of people in the room,” he said, noting the township set up an overflow area in case more than 25 people showed up and it still has a livestream for those who don’t want to attend in person.

    It went well Tuesday night, Bennett said.

    State Sen. Jeff Irwin, D-Ann Arbor, said state lawmakers are scrambling to address the issue of public meetings and he expects a

    Continue reading